[ad_1]
“Preliminary evidence suggests that both doses of the two-dose COVID-19 vaccine … are necessary to provide adequate protection against the delta variant,” the EVA said in a statement.
“To benefit from the highest level of protection, it is necessary to follow the recommended vaccination course,” he added.
The delta strain, which the EVA calls a “worrying option,” is “spreading rapidly in Europe and could seriously hamper pandemic control efforts,” the agency said.
Infections of the delta strain, which was first detected in India, according to the European Center for Disease Prevention and Control, are likely to account for 90% by late summer. all cases of coronavirus infection.
“This means that countries must intensify vaccination programs, including the delivery of second doses, when recommended, and close the gaps and opportunities for new options as soon as possible,” the EVA emphasized.
To date, the EVA has approved four coronavirus vaccines: BioNTech / Pfizer, AstraZeneca and Moderna, and Johnson & Johnson, single-dose.
